🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Guangzhou
Clinical trial register · China

Clinical Trials in Guangzhou

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University451 Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University181 Nanfang Hospital, Southern Medical University138 AstraZeneca133 Guangdong Provincial People's Hospital81
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
3318 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC
NCT07503379mHSPC
Yonghong Li
Phase 2
109
Guangzhou, Meizhou
2026-04-16
Recruiting
Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer
NCT07412613Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer
Akeso
Phase 3
386
Guangzhou
2026-04-15
Recruiting
Becotatug Vedotin Plus Pucotenlimab and Platinum Chemotherapy in Locally Advanced Epidermal Growth Factor Receptor (EGFR)-Positive Head and Neck Squamous Cell Carcinoma
NCT07814287Head and Neck Squamous Cell Carcinoma, HNSCC
Xuekui Liu
Phase 2
40
Guangzhou
2026-04-15
Recruiting
Underwater Endoscopic Mucosal Resection Versus Endoscopic Submucosal Dissection for the Treatment of Small Rectal Neuroendocrine Tumors
NCT07759960Rectal Neuroendocrine Tumor
Nanfang Hospital, Southern Medical University
Not applicable
174
Guangzhou
2026-04-14
Active, closed
Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand Treatment
NCT07663903Severe Hemophilia A
Hangzhou Gensciences Biopharmaceutical Co., Ltd.
Phase 3
60
Tianjin, Fuyang, Fuzhou, Ganzhou, Guangzhou, Hefei, Huai'an, Jinan
2026-04-14
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
NCT07541521Stage IIB-III NSCLC, Sleeve Lobectomy, Robotic Surgery, Neoadjuvant Chemoimmunotherapy
Shanghai Chest Hospital
Observational
100
Fuzhou, Guangzhou, Shenzhen, Nanjing, Qingdao, Tianjing, Shanghai
2026-04-13
Recruiting
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
NCT07472517Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Boehringer Ingelheim
Phase 3
670
Beijing, Bengbu, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Harbin
2026-04-13
Recruiting
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid Tumors
NCT07414836Advanced Solid Tumor
BeOne Medicines
Phase 1
84
Beijing, Chongqing, Fuzhou, Guangzhou, Yichang, Shanghai
2026-04-13
Recruiting
QL1706 Plus Lenvatinib in Previously Treated Penile Cancer
NCT07384416Penile Cancer
Sun Yat-sen University
Phase 2
47
Guangzhou
2026-04-10
Recruiting
Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.
NCT07537998Low Anterior Resection Syndrome, Rectal Cancer
Pei-Rong Ding
Phase 2/3
160
Guangzhou
2026-04-10
Recruiting
The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?
NCT07512115Myopia, Refractive Ametropia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
224
Guangzhou
2026-04-08
Recruiting
Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Clinical Trial
NCT07512102Myopia, Refractive Ametropia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
100
Guangzhou
2026-04-08
Recruiting
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
NCT07403721Metastatic or Locally Advanced Solid Tumors With Microsatellite Instability-high (MSI-H) or Mismatched Repair Deficiency (dMMR)
Amgen
Phase 1
464
Guangzhou, Shanghai
2026-04-08
Recruiting
Comparison of Anticoagulant Effects of Different Doses of Nafamostat in Continuous Renal Replacement Therapy (CRRT) in the Intensive Care Unit (ICU)
NCT07469072Continuous Renal Replacement Therapy (CRRT)
Zhujiang Hospital
Phase 2
92
Guangzhou
2026-04-07
Recruiting
HWS116 Monotherapy in Patients With Advanced Solid Tumors
NCT07413328Advanced Solid Tumors
Wuhan Humanwell Innovative Drug Research and Development Center Limited Company
Phase 1
56
Guangzhou
2026-04-07
By invitation
Peritoneal Dialysis (PD) Specialized LLM for PD Management
NCT07539428Peritoneal Dialysis (PD), Large Language Models
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
150
Guangzhou
2026-04-05
Recruiting
RC148 Plus Platinum-Based Chemotherapy vs Tislelizumab Plus Platinum-Based Chemotherapy for First-Line Squamous Non-Small Cell Lung Cancer (sqNSCLC)
NCT07416474Non-Small Cell Lung Cancer
RemeGen Co., Ltd.
Phase 3
574
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Dongguan, Guangzhou
2026-04-03
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Recruiting
Efficacy and Safety of Minocycline in Acute Spontaneous Intracerebral Hemorrhage
NCT07338175Intracerebral Hemorrhage
Beijing Tiantan Hospital
Phase 3
1,192
Beijing, Chongqing, Guangzhou, Baoding, Zhangjiakou, Zunhua, Mengzhou, Nanle
2026-04-02
Recruiting
FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis
NCT07464392Acute Pancreatitis
Changhai Hospital
Not applicable
150
Fuzhou, Quanzhou, Guangzhou, Qingyuan, Zhanjiang, Shanghai
2026-04-02
Not yet open
An Observational Clinical Study on the Association of Intestinal Ruminococcus Gnavus and Its Derived Biogenic Amines With Metabolic Dysfunction-associated Fatty Liver Disease
NCT07455149Metabolic Dysfunction-associated Fatty Liver Disease
Zhujiang Hospital
Observational
200
Guangzhou
2026-04-01
Not yet open
Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy
NCT07497958Renal Cell Carcinoma (RCC), Renal Function Abnormal
Sun Yat-sen University
Not applicable
174
Guangzhou
2026-04-01
Not yet open
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
NCT07413952NSCLC
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
45
Guangzhou
2026-04-01
Active, closed
An Ecological Momentary Intervention for Mental Health in Individuals With Ankylosing Spondylitis
NCT07647965Ankylosing Spondylitis (AS), Mental Health
The Hong Kong Polytechnic University
Not applicable
36
Guangzhou
2026-04-01
Not yet open
Observational Clinical Study on the Association Between Lactate-mediated Gut Microbiota Alterations and Disease Progression in Liver Cirrhosis.
NCT07455175Cirrhosis
Zhujiang Hospital
Observational
200
Guangzhou
2026-04-01
Recruiting
Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study
NCT07539792Sellar Tumor, Endonasal Surgery, Csf Leakage
Nanfang Hospital, Southern Medical University
Phase 2
126
Foshan, Gaozhou, Guangzhou, Huizhou, Zhaoqing, Liuzhou
2026-04-01
Not yet open
Butylphthalide for Brain Edema After Endovascular Treatment
NCT07528456Acute Ischemic Stroke
Nanfang Hospital, Southern Medical University
Phase 4
100
Dongguan, Guangzhou, Heyuan, Qingyuan, Shaoguan, Haikou, Ganzhou
2026-04-01
Recruiting
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
NCT06768931Breast Cancer, Triple Negative Breast Cancer (TNBC), Early Stage Breast Cancer, Immunotherapy
Sun Yat-sen University
Phase 2
192
Lanzhou, Dongguan, Guangzhou, Zhanjiang, Zigong
2026-04-01
By invitation
HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
NCT07517510Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)
Guangdong Second Provincial General Hospital
Phase 2
40
Guangzhou
2026-04-01
Recruiting
A Study of HDM2020 in Patients With Advanced Sq-NSCLC
NCT07638891Squamous Non-small Cell Lung Cancer(NSCLC)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
150
Guangzhou
2026-04-01
Recruiting
Effects of Different Tunnel Methods in PICC Catheterization
NCT07594704PICC Line Placement, PICC-associated Thrombosis
Sun Yat-sen University
Not applicable
284
Guangzhou
2026-04-01
By invitation
VEN+IDAC vs IDAC in AML
NCT07537257AML (Acute Myelogenous Leukemia)
Guangdong Second Provincial General Hospital
Phase 2/3
232
Guangzhou
2026-04-01
Recruiting
Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study
NCT07295821Lung Cancer
AstraZeneca
Phase 2
60
Beijing, Changchun, Changsha, Chengdu, Foshan, Fuzhou, Guangzhou, Harbin
2026-04-01
Not yet open
Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07457099Locally Advanced Oral Squamous Cell Carcinoma, Locally Advanced Oropharyngeal Squamous Cell Carcinoma
Zhujiang Hospital
Observational
85
Guangzhou
2026-04-01
Recruiting
A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer
NCT07352930Breast-Conserving Surgery
Guangdong Provincial People's Hospital
Not applicable
172
Guangzhou
2026-04-01
Not yet open
Transcutaneous Auricular Vagus Nerve Stimulation Combined With Tailor-Made Notched Music Training Therapy for Chronic Subjective Tinnitus
NCT07469969Chronic Subjective Tinnitus
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
386
Guangzhou
2026-04-01
Recruiting
A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates
NCT07520760HER 2 Negative Breast Cancer
Sun Yat-sen University
Phase 2
52
Guangzhou
2026-04-01
Recruiting
Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma
NCT07750067Melanoma Metastatic, NRAS Mutation
Sun Yat-sen University
Phase 2
37
Guangzhou
2026-04-01
Not yet open
JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer
NCT07497074Cervical Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 2
78
Guangzhou, Hangzhou
2026-04
Not yet open
Nutritional + Usual Corticosteroids Randomized Trial for Immune-Related pneumoniA - Therapeutic Utilization Evaluation
NCT07554885Immune Checkpoint Inhibitor-Related Pneumonitis, Drug-Related Side Effects and Adverse Reactions, Neoplasms
Guangzhou Institute of Respiratory Disease
Not applicable
60
Guangzhou
2026-04
Not yet open
Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis
NCT07523165Bronchiectasis
The First Affiliated Hospital of Guangzhou Medical University
Phase 2
150
Guangzhou
2026-04
Not yet open
Extended Time Window Intravenous Thrombolysis Registry for Acute Ischemic Stroke
NCT07536074Stroke, Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
3,000
Guangzhou, Guankou
2026-04
Not yet open
First-In-Human Study of KHN922 for Injection
NCT07514975Advanced Solid Tumors Cancer
Chengdu Kanghong Biotech Co., Ltd.
Phase 1/2
276
Guangzhou
2026-04
Not yet open
A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia
NCT07574866Pneumonia
Zhonghao Fang
Observational
500
Guangzhou
2026-04
Not yet open
A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer
NCT07507526Gastric Adenocarcinoma
Sun Yat-sen University
Phase 2
76
Guangzhou
2026-04
Not yet open
Extended Time Window Intravenous Tenecteplase Thrombolysis Registry for Acute Ischemic Stroke
NCT07536165Stroke, Acute Ischemic Stroke
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
3,000
Guangzhou, Guankou
2026-04
Recruiting
Evaluation of TQ-B3234 Capsules in Patients With Symptomatic, Non-Surgical Type 1 Neurofibromatosis-Associated Plexiform Neurofibromas
NCT07407803Plexiform Neurofibroma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3
177
Hefei, Beijing, Chongqing, Fuzhou, Lanzhou, Guangzhou, Nanning, Guiyang
2026-03-31
Not yet open
FFR-Guided Revascularization in Atherosclerotic Renal Artery Stenosis
NCT07511309Atherosclerotic Renal Artery Stenosis, Fractional Flow Reserve, Optimal Medical Therapy, Stent Implantation
Chinese Academy of Medical Sciences, Fuwai Hospital
Not applicable
300
Guangzhou, Harbin, Zhengzhou, Nanjing, Nanchang, Dalian, Changchun, Jinan
2026-03-31
Active, closed
Clinical Characteristics of Recompensation
NCT07651683Cirrhosis, Alcohol Related Liver Disease, HBV (Hepatitis B Virus), Recompensation
Third Affiliated Hospital, Sun Yat-Sen University
Observational
300
Guangzhou
2026-03-31
Recruiting
A Study of E6742 in Participants With Systemic Lupus Erythematosus
NCT07515014Systemic Lupus Erythematosus
Eisai Co., Ltd.
Phase 2
256
Bengbu, Beijing, Chongqing, Guangzhou, Shantou, Nanning, Guiyang, Luoyang
2026-03-31
Recruiting
BC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
NCT07469774Locally Advanced or Metastatic Solid Tumors
Biocity Biopharmaceutics Co., Ltd.
Phase 1/2
111
Guangzhou
2026-03-31
Not yet open
Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer
NCT07469956Pancreatic Cancer Resectable
Sun Yat-sen University
Phase 2
30
Guangzhou
2026-03-31
Recruiting
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
NCT07418749Recurrent Cervical Cancer, Metastatic Cervical Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
398
Guangzhou
2026-03-30
Recruiting
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
NCT07455734Advanced Solid Tumor Cancer
BioNTech SE
Phase 1/2
533
Chongqing, Guangzhou, Hangzhou, Shanghai, Tianjin
2026-03-30
Not yet open
Real-World Study on Efficacy and Influencing Factors of Immunotherapy for Pan-Cancer Lymph Node Metastases.
NCT07540377Malignant Solid Tumors With Lymph Node Metastasis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
5,000
Guangzhou
2026-03-30
Recruiting
Remote Ischemic Preconditioning for Aute Type A Aortic Dissection Surgery
NCT07383909Aortic Dissection Type A
Fujian Medical University
Not applicable
1,312
Hefei, Fuzhou, Xiamen, Guangzhou, Harbin, Zhengzhou, Changsha, Dalian
2026-03-29
Recruiting
The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC
NCT07507513Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
288
Guangzhou
2026-03-28
By invitation
Clinical Study on the Treatment of Gastrointestinal Dysfunction After Knee Joint Surgery Under General Anesthesia With Floating Needle
NCT07607249Gastrointestinal Dysfunction
Zhenyu Zhang
Not applicable
72
Guangzhou
2026-03-27
Recruiting
An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
NCT07493044Advanced Hepatocellular Carcinoma (HCC), GPC3 Positive Hepatocellular Carcinoma
Guangzhou FineImmune Biotechnology Co., LTD.
Phase 1
15
Guangzhou
2026-03-27
Recruiting
Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcinoma
NCT07518602Extrapulmonary Neuroendocrine Carcinoma (EP-NEC)
Sun Yat-sen University
Phase 2
34
Guangzhou
2026-03-27
Recruiting
A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity
NCT07478822Upper Limb Spasticity
Chongqing Claruvis Pharmaceutical Co., Ltd.
Phase 3
300
Beijing, Chengdu, Guangdong, Guangzhou, Hefei, Huai'an, Kaifeng, Kunming
2026-03-27
Recruiting
Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines
NCT07415551Allergic Diseases, Chronic Spontaneous Urticaria (CSU)
Yuhan Corporation
Phase 2
150
Guangzhou, Shenzhen
2026-03-26
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe
Eli Lilly and Company
Phase 2
1,431
Binzhou, Changzhou, Chengdu, Chongqing, Foshan, Guangzhou, Harbin, Hefei
2026-03-26
Recruiting
To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus
NCT07447986Systemic Lupus Erythematosus (SLE)
Hangzhou Sumgen Biotech Co., Ltd.
Phase 2
120
Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Shenzhen, Guilin, Nanning
2026-03-26
Recruiting
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
NCT07493265Narcolepsy
Eisai Inc.
Phase 2
64
Beijing, Changchun, Guangdong, Guangzhou, Jinan, Nanchang, Shanghai, Zhengzhou
2026-03-26
Recruiting
Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
NCT07388680Radiation-induced Lung Injury, Immune-related Pneumonia
Beijing Continent Pharmaceutical Co, Ltd.
Phase 2/3
298
Hefei, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou, Maoming, Shenzhen
2026-03-26
Not yet open
Probiotics Combined With Targeted Therapy Plus Immunotherapy in Bladder-Preserving Setting for Patients With MIBC
NCT07474064Muscle Invasive Bladder Cancer (MIBC)
chenxu
Phase 2
146
Guangzhou
2026-03-26
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
NCT07293351Advanced Renal Cell Carcinoma (RCC)
Bristol-Myers Squibb
Phase 1/2
474
Beijing, Guangzhou, Tianjin, Harbin, Changsha Shi, Nanjing, Shanghai Shi
2026-03-26
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
NCT07326709Huntington Disease
Novartis Pharmaceuticals
Phase 3
770
Guangzhou, Wuhan, Changsha, Chengdu, Hangzhou
2026-03-24
Recruiting
Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation
NCT07441382Atrial Fibrillation (AF), Stroke, Hemorrhage, Frailty
Guangdong Provincial People's Hospital
Not applicable
200
Guangzhou
2026-03-24
Active, closed
Large Language Model-Based Emotional Management for Breast Cancer Patients
NCT07452055Primary Breast Cancer
Nanfang Hospital, Southern Medical University
Not applicable
440
Guangzhou
2026-03-24
Active, closed
Evaluation of the Safety and Efficacy of the D.D.C Dual-control Technology Spectacle Lenses in Delaying the Progression of Myopia: a Randomized Controlled Trial
NCT07264361Myopia, Progressive
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
316
Guangzhou
2026-03-23
Recruiting
Phase II Study of Iparomlimab and Tuvonralimab (QL1706) in Combination With Albumin-Bound Paclitaxel and Lenvatinib as Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
NCT07530445Second-Line Therapy for Unresectable or Metastatic Biliary Tract Cancer
Sun Yat-sen University
Phase 2
40
Guangzhou
2026-03-23
Recruiting
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
NCT07355296Proteinuric Kidney Diseases
Boehringer Ingelheim
Phase 2
132
Beijing, Chengdu, Guangzhou, Nanchang, Nanjing, Nanning, Shanghai, Sichuan
2026-03-23
Not yet open
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase Ⅱ Clinical Study to Evaluate the Efficacy and Safety of CMS-D001 in Adult Patients With Moderate to Severe Atopic Dermatitis
NCT07465120Moderate to Severe Atopic Dermatitis
Dermavon Holdings Limited
Phase 2
160
Beijing, Fuzhou, Guangzhou, Shenzhen, Haikou, Shijiazhuang, Tangshan, Zhengzhou
2026-03-20
Recruiting
Clinical Trial of Neoadjuvant mFOLFOX Plus Alvenor for LARC Patients With High YWHAB Expression
NCT07176182Rectal Cancer Patients, Rectal Cancer Stage II, Rectal Cancer Stage III
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2
236
Guangzhou
2026-03-20
Recruiting
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
NCT07481786Lung Adenocarcinoma, Brain Metastases, Radiotherapy, Intensity-Modulated, Bevacizumab
Sun Yat-sen University
Phase 3
220
Chongqing, Guangzhou
2026-03-20
Recruiting
Radiotherapy After Prostatectomy for Node Positive Prostate Cancer
NCT07477626Prostate Cancer (Post Prostatectomy), Radiotherapy; Image-Guided, Prostate Cancer Non-Metastatic, Androgen Deprivation Therapy
Sun Yat-sen University
Phase 3
372
Dongguan, Guangzhou, Zhanjiang, Zhengzhou, Chengdu, Hangzhou, Beijing, Shanghai
2026-03-20
Recruiting
Early Complications After Flow Diverter Versus Stent-Assisted Coiling for Unruptured Wide-Neck Intracranial Bifurcation Aneurysms
NCT07754188Unruptured Intracranial Aneurysm, Intracranial Bifurcation Aneurysm, Wide-Neck Aneurysm
Nanfang Hospital, Southern Medical University
Observational
274
Guangzhou
2026-03-19
Recruiting
A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients
NCT07446738Chronic Rhinosinusitis With Nasal Polyps
AstraZeneca
Observational
200
Changchun, Changsha, Chengdu, Guangzhou, Haikou, Kunming, Nanchang, Nanjing
2026-03-19
Recruiting
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
NCT07446153Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.
Phase 1/2
282
Guangzhou, Shenyang
2026-03-19
Recruiting
Comparative Analysis of Two Transforaminal Lumbar Interbody Fusion (TLIF) Procedures in the Treatment of Single-Level Lumbar Spinal Stenosis (LSS): A Single-Center, Prospective, Randomized Controlled Trial
NCT07588555Lumbar Spinal Stenosis
The Third Affiliated Hospital of Southern Medical University
Not applicable
276
Guangzhou
2026-03-18
Recruiting
Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)
NCT07543796Postoperative Analgesia After Unilateral Hip Arthroplasty
Beijing Tide Pharmaceutical Co., Ltd
Phase 2
200
Guangzhou
2026-03-18
Recruiting
MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)
NCT07431827Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC
Phase 3
400
Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Hshijiazhuang, Wuhan, Changsha
2026-03-18
Recruiting
SBRT Versus Surgical Resection for Small HCC
NCT07381660Hepatocellular Carcinoma (HCC)
Sun Yat-sen University
Phase 3
390
Guangzhou
2026-03-18
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Recruiting
PregnAncy-Related Aortic DISsEction in China
NCT07672210Pregnancy Complication, Aortic Dissection, Marfan Syndrome, Loeys-Dietz Syndrome
DeltaHealth Hospital · Shanghai
Observational
500
Shanghai, Beijing, Guangzhou, Wuhan
2026-03-17
Recruiting
Efficacy and Safety of Tinengotinib Tablets Combined With Fulvestrant Injection in Patients With HR Positive and HER-2 Negative Recurrent or Metastatic Breast Cancer Who Have Failed Prior Treatment
NCT07498478Breast Cancer
TransThera Sciences (Nanjing), Inc.
Phase 2
94
Guangzhou, Wuhan, Changsha, Nanjing, Jinan, Linyi, Hangzhou, Beijing
2026-03-17
Recruiting
A Phase III Study of JSKN016 Versus Treatment of Physician's Choice in Patients With Triple-Negative Breast Cancer Who Have Failed Standard of Care
NCT07533123Triple Negative Breast Cancer
Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Phase 3
364
Guangzhou
2026-03-17
Recruiting
HARMONY Trial : To Evaluate a Therapeutic and Monitoring Device(NOVAtria System) for Heart Failure Management
NCT07402239Heart Failure
United Innomed(Shanghai) Limited
Not applicable
330
Fuzhou, Lanzhou, Guangzhou, Guiyang, Zhengzhou, Changsha, Nanchang, Shanghai
2026-03-16
Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
NCT07291076Hepatocellular Carcinoma (HCC)
Bristol-Myers Squibb
Phase 1/2
198
Hefei, Beijing, Chongqing, Fuzhou, Guangzhou, Nanning, Harbin, Nanyang
2026-03-16
Recruiting
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
NCT07448142Colorectal Cancer (CRC)
Sun Yat-sen University
Phase 2
50
Guangzhou
2026-03-15
Recruiting
Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies
NCT07467122Advanced Mesenchymal Malignancies
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 1
15
Guangzhou
2026-03-15
Recruiting
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
NCT07412470Kidney Transplant Rejection
Sanofi
Phase 2/3
526
Beijing, Chengdu, Guangzhou, Hangzhou, Jinan, Nanchang, Nanning, Shanghai
2026-03-13
Active, closed
EFficacy and safEty of cRisugabalin on nocipLastic paIn in Patients With Parkinson's Disease (RELIEF-PD): a Multicentre, Double-blind, Randomised Controlled Trial
NCT07483398PARKINSON DISEASE (Disorder)
Guangdong Provincial People's Hospital
Phase 4
166
Guangzhou
2026-03-13
Recruiting
Effect of EIT-guided PEEP in ARDS Patients
NCT06990477ARDS (Acute Respiratory Distress Syndrome)
Southeast University, China
Not applicable
2,400
Hefei, Shanghai, Guangzhou, Zhengzhou, Hangzhou, Nanjing, Xuzhou, Nanchang
2026-03-13
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT07221149Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb
Phase 2/3
690
Beijing, Fuzhou, Guangzhou, Nanning, Harbin, Weihui, Zhengzhou, Wuhan
2026-03-13
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
NCT07361510Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 3
750
Beijing, Fuzhou, Xiamen, Zhangzhou, Guangzhou, Shantou, Nanning, Harbin
2026-03-12
Recruiting
Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma
NCT07362979Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
243
Dongguan, Guangzhou, Shenzhen, Zhanjiang
2026-03-12
Recruiting
Andamertinib With or Without Platinum-doublet Chemotherapy Versus Platinum-doublet Chemotherapy in Patients With NSCLC Harboring Atypical EGFR Mutations
NCT07336732Non-Small-Cell Lung Cancer
Avistone Biotechnology Co., Ltd.
Phase 2
40
Guangzhou
2026-03-11
Rows per page Showing 401–500 of 3318
Previous 3 4 5 6 7 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/guangzhou?page=5

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.